Sitemap
Technologies
- Pharmaceuticals
- Use of miR-122* for Treating Cancer
- TREATMENT OF ARDS ASSOCIATED WITH COVID-19
- The influence of cannabinoids on reconstitution of hematological system after Bone Marrow transplantation
- Targeting The Hypoxia Responses of Solid Tumors as a Novel Therapeutic Approach
- TARGETING NEUTROPHILS AS A THERAPY FOR SEVERE COVID-19 INFECTION
- Supplementation Of Milk Formulas With Microvesicles Isolated From Milk
- Small molecules for the treatment of APBD and other glycogen storage diseases
- REPURPOSING OF FDA-APPROVED DRUGS FOR INHIBITING THE INFLAMMATORY PROCESS ASSOCIATED WITH CORONA VIRUS INFECTION
- Protease Activated Receptors (PAR) Mimetics for Cancer Treatment.
- Pluripotent Stem Cells, identical except for different Sex Chromosomes (XX vs. XY), and designed for drug development
- Novel Targeted Therapy for Depression and Cancer
- Monocyte-Derived Dendritic Cell Subpopulations for use in therapy
- Modulation of Myofibroblast Apoptosis for Treatment of Lung Fibrosis.
- Method Of Selecting Cell Populations Enriched With Desired Cells.
- Livin-Derived Peptides As Novel Targeted Cancer Treatment
- Livin for formation of platelets
- Inhibition of Ornithine Aminotransferase for Treatment of Hepatocellular Carcinoma.
- Hepatoprotective effect of alpha 1 anti trypsin
- Decoy Oligonucleotides Corresponding to NF-KappaB Binding Site in MGMT Promoter for Cancer Treatment and Drug Resistance.
- Clinical Grade Embryonic Stem Cells for Multiple Indications
- Anti Biofilm for the Treatment of Acne Vulgaris and Increased Susceptibility of Certain Bacterial Strains For Antibiotics
- AN INHALED FORMULATION OF FDA-APPROVED DRUGS FOR TREATMENT OF ARDS
- An artemisinin derivative for the Treatment of CMV Viral Infections.
- A naturally-occurring peptide as a potential treatment for cancer
- A method for induction of immune-regulatory properties on mesenchymal stem cells to be used for cell therapy
- Molecular Diagnostics
- HIGH-THROUGHPUT TEST FOR SARS-COVID-2 VIRUS IN PATIENT SAMPLES
- Erlotonib analogues for the noninvasive identification of EGFR tyrosine kinase inhibitor-responsive non-small cell lung carcinoma tumors using positron emission tomography
- Circulating microRNAs as Biomarkers for B-Cell Depletion Therapy/ Rituximab in Neuromyelitis Optica
- A Novel Flow Cytometry Tool for Fibrosis Scoring Through Hepatic Stellate Cell Differentiation
- Medical Devices
- UFree - intra-urethral mechanical catheter (BioDesign)
- Symphonic scalpel – Nerve detecting laparoscopic clamp (BioDesign)
- Optic Neuritis & Multiple Sclerosis Visual Tests
- Non invasive aerosol free PAP ventilation
- Iontophoretic Ocular Drug Delivery
- Icough - ACCUMULATIVE BREATH COUGHER
- CT Perfusion Reference Phantom
- Bolus Propagation Esophagography (BPE)
- Aortic Pacemaker
- AlgoShield: preventing hernia mesh adhesions
- Life Science & Biotech
- Human Stem Cell-Derived Neural Precursors for Treatment of CNS Autoimmune Disease.
- Allogeneic Tumor Cell Vaccination
R&D Services
- Clinical Development
- Preclinical and Regulatory Development
- Bioassays Development and Performance
- Disease Models and Experimental Animal Studies
- Hadasit's Units & Labs
- Biotechnology and Radiobiology Laboratory
- The Center for Hyperpolarized MRI Molecular Imaging
- Coagulation Unit
- Experimental Neurology Laboratory
- BrainLabs
- Tissue Typing and Immunogenetics Unit
- Liver Unit
- Clinical Virology Unit
- Clinical Microbiology Unit
- Blood Bank
- The Department of Obstetrics and Gynecology
- The Oncology Research Laboratory
- Ocular Oncology and Pathology Laboratory
- The Surgical Innovation and Technology Center
- Hadassah GMP Facility
- Genetics and Metabolic Diseases
- Metabolic and Enzyme Laboratory
- Pathology Laboratories
- Rat In vivo Experiment Services
- Central Laboratory
- Clinical Immunology and Allergy Unit
- Viral Vector Construction Unit
- Pharmacogenomic Unit